Conformationally-constrained molecules that selectively recognise the surfaces of proteins have the potential to direct the path of protein folding. Such molecules are of therapeutic interest because the misfolding of proteins, especially that which results in fibrillation and aggregation, is strongly correlated with numerous diseases. Here we report the novel use of S/O interactions as a conformational control element in a new class of non-peptidic scaffold that mimics key elements of protein surfaces. These molecules disrupt the fibrillation of islet amyloid polypeptide (IAPP), a process that is implicated in the pathology of type II diabetes.
Introduction
Correctly folded proteins have myriad roles critical for life, including structural support, signal mediation and catalysis. Conversely, misfolded forms are associated with numerous diseases, including neurodegenerative disorders such as Alzheimer's and Parkinson's, and non-neuropathic conditions such as type II diabetes. 1 The use of small molecules to mediate aberrant protein folding is a hugely appealing therapeutic strategy, [2] [3] [4] however there are few rationally designed examples. A potential solution is the use of protein surface mimetics that modulate the energy landscape of protein folding via selective recognition of complementary protein surfaces, analogous to nature's chaperone proteins. Work by our group and others has established several families of synthetic protein surface mimetics that reproduce key recognition features of protein secondary structure [5] [6] [7] [8] [9] and can thereby affect the pathways of protein folding.
10,11
In order to maximise target-binding affinity, protein surface mimetics are based on conformationally pre-organised scaffolds. This increases the population of the desired conformer and thus reduces the entropic cost of binding. Previous nonpeptidic scaffolds have taken advantage of hydrogen bonding, [12] [13] [14] [15] [16] the stereoelectronic preferences of secondary aryl amides, 13, 17, 18 steric repulsion between vicinal cyclic systems, 19, 20 dipolar repulsion, 21, 22 cyclisation, 23 and metal templation 24 to provide conformational pre-organisation (Fig. 1) .
With the aim of expanding the toolkit of scaffolds for protein surface mimicry we set out to explore additional conformational determinants that promote pre-organisation. The S/O interaction involves a low-lying C-S s* molecular orbital that accepts electron density from an adjacent oxygen lone pair.
25-27
Many observations of this effect have been made ex post factofrequently upon inspection of X-ray diffraction data. However, there are few examples in which the interaction is incorporated as a conformational determinant of rationally designed compounds. The effect of the S/O interaction is highlighted by quantum mechanical simulation of a benzothiazole model system in which population distribution is evaluated as a function of two key dihedral angles (F 1 and F 2 , Fig. 2A) . A 1,5-S/O interaction heavily biases the conformation towards one in which the sulfur and oxygen atoms are co-planar and adjacent to each other (F 1 and F 2 of 0 , Fig. 2B ), with a barrier to rotation about F 1 of 7.4 kcal mol À1 when F 2 is constant at 0 . In contrast, a model system containing an oxygen atom in place of sulfur is less biased towards a single conformation, and has an approximately equal preference for two out-of-plane geometries (Fig. 2B ).
28
Here we explore the 1,5-S/O interaction as a determinant of conformation in a benzothiazole-thiophene scaffold. This scaffold projects three substituents (R 2 , R 3 , R 4 ) that mimic the i, i + 3/4 and i + 7 side-chains vectors of one face of an a-helix.
Results and discussion
The synthesis began with the preparation of 5-nitrobenzo [d] thiazol-2-amine 1 on a multi-gram scale from 2-uoro-5-nitroaniline in two steps. 35 † A range of R 1 and R 2 groups were introduced either by N-acylation and N-alkylation (Scheme 1, Route 1), or an alternative sequence in which the amine was diazotized and substituted with chlorine, allowing introduction of substituted amines by nucleophilic substitution followed by N-acylation (Scheme 1, Route 2). † Reduction of the aromatic nitro group of compounds 5-7 with hydrogen under palladium on carbon catalysis gave anilines that were regioselectively (Fig. 3A) . Substituents R 2 and R 3 of 20 are separated by approximately 5Å in the desired conformation. This separation is greater in all other conformations and is a maximum of approximately 6.5Å if an anti-arrangement of these groups is adopted. Since 5Å is the accepted cut-off distance for an observable nOe in a non-exible system, 36 the presence of an nOe correlation between the hydrogens of these substituents indicates that the desired conformation is likely to be a signicant contributor to the solution phase conformational ensemble.
The X-ray crystal structure of iodide 24, an analogue of 19-23, conrms the presence of two 1,5-S/O interactions (Fig. 3B) . † There is planarity about both the carbamate-benzothiazole and urea-thiophene units, and the S/O distances are 2.7Å and 2.9Å, respectively, smaller than the sum of the van der Waals radii of sulfur and oxygen (3.3Å). The projection of three substituents (R 2 , R 3 and R
4
) is in good agreement with sidechains i, i + 4 and i + 7 of a canonical a-helix (Fig. 3C ). This positioning is analogous to the previously reported oligopyridylamide and oligobenzamide scaffolds.
10,13 A six-point RMSD of 1.4Å was calculated from the superposition of three a-carbons and three b-carbons of the a-helix with the corresponding atoms of the scaffold.
37
In order to assess the capacity of the benzothiazole-thiophene scaffold to act as a protein surface mimetic, we studied the ability of appropriately functionalised variants to disrupt the brillation of islet amyloid polypeptide (IAPP). The selfassociation of intrinsically-disordered 37-residue IAPP (Fig. 4A ) ultimately leads to amyloid brils (highly-ordered b-rich aggregates) which are the main component of the protein deposits in the pancreatic islets of type II diabetes patients.
38,39
In the presence of phospholipid membranes_-such as those found within biological systems_-the N-terminus of IAPP (residues 5-22) populates a-helical states before undergoing brillisation (Fig. 4B) . 40, 41 The stabilisation of these membranebound a-helical states attenuates the formation of IAPP brils 41 and, as recent evidence suggests, decreases the cellular toxicity of IAPP. 41, 42 This indicates therapeutic applications of IAPP helix stabilisers. In our previous work, scaffolds functionalised with acidic, hydrophobic and acidic groups that overlay with positions i, i + 3/4 and i + 7 of an a-helix, respectively, were highly effective disruptors of membrane-catalysed IAPP brilla-tion. 10, 11, 42 These surface mimetics were complementary to sidechains of the a-helical N-terminus of IAPP (postulated to be Arg11, Asn14/Phe15 and His18) and stabilised its helix formation (Fig. 4C) . 42 We measured the brillation of IAPP using a thioavin T (ThT) assay 43 in the presence of a model membrane system.
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The uorescence intensity of ThT correlates with the extent of protein bril formation. The assay conrmed that ability of the benzothiazole-thiophenes to disrupt the brillation of IAPP. This can be seen by the lower end-point uorescence intensity of the samples containing 19, 22 and 23 relative to the IAPP control (Fig. 5A) . Additionally, the IAPP brillation process is delayed in the presence of these three compounds in comparison to control, seen by the extended times to half-maximal brillation (t 1/2 ) of these samples (Fig. 5B) . The results of the ThT assay were conrmed by electron microscopy, which showed that treatment of IAPP with 19 and 22 gives rise to amorphous aggregates whereas 21 gives rise to a combination of amorphous aggregates and ordered brils (ESI Fig. 3 †) . Furthermore, circular dichroism (CD) conrmed that compound 19 disrupts the transition of IAPP from its initial a-helical conformation (a spectrum characterised by two minima at 208 and 222 nm) to a b-sheet conformation (a spectrum characterised by a single minimum at approximately 215 nm) in the presence of a model membrane system (Fig. 6) .
The most striking feature of the structure-activity relationship is that the active compounds bear three-carbon carboxylic acid substituents at positions R 2 and R 4 , however the inactive compounds, 20 and 21, both bear two-carbon carboxylic acids substituents at these positions. This indicates that the length of the acidic substituents at positions R 2 and R 4 is critical to the interaction between the protein and the small molecule, consistent with the formation of specic contacts. The central hydrophobic substituent (R 3 ) was also sensitive to modication.
Compound 23, which differs from 22 only by the absence of this central substituent, was a less effective inhibitor of brillation. This is consistent with a previous observation that the central hydrophobic substituent is sensitive to modication within an oligopyridylamide scaffold displaying an analogous set of functional groups.
43

Conclusions
We have synthesised a new non-peptidic protein surface mimetic based on a benzothiazole-thiophene scaffold that is conformationally pre-organised by two 1,5-S/O interactions. The scaffold directs three side-chains to positions i, i + 3/4 and i + 7 of an a-helix. The S/O interaction was evaluated as a determinant of conformation by calculation, X-ray crystallography and solution-phase NMR spectroscopy. A focussed library of conformationally constrained scaffolds displaying a range of functional groups act as protein surface mimetics that disrupt membrane-catalysed islet amyloid polypeptide (IAPP) brillation, a pathway strongly associated with the pathology of type-II diabetes. C.
